Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences

Register before end of July to receive maximum savings of $600 on Bio World China, Biologic Manufacturing, and Clinical Trials Supply Asia Conferences

FARMINGTON, Conn., July 12, 2012 /PRNewswire-iReach/ -- Successful businesses stay connected to the biotech market, network, and forge new business relationships with industry leaders at global biotech conferences with help from Global Information Inc. Attendees go to learn about new innovations, how to implement effective strategies, and tactics for minimizing costs and risks while overcoming regulatory and technological hurdles.

(Photo: http://photos.prnewswire.com/prnh/20120712/CG39694)

Global Information announces limited early bird registrations for three important biotech and pharmaceutical conferences in Shanghai and Singapore.

Bio World China 2012

November 5 – 7, 2012 – Shanghai, China

Facilitate innovation and manufacturing of affordable and high quality vaccine and biopharmaceutical drugs in China. This conference is China's largest biopharmaceutical industry gathering of decision makers across C-level management in the realms of biologics, biosimilars, vaccines and blood/plasma products. Bio World China 2012 will feature over 50 CEOs from China's major biopharmaceutical companies, 300+ senior decision makers from all major biopharmaceutical players from China and globally, 50+ case studies ranging from investments, cell culture engineering, blood product developments, vaccines industry trends and R&D updates, stem cell technologies and biomanufacturing best practices. Additionally, ample networking time ensures quality face time to forge lasting business relationships.

Save $600 by registering before July 31! More information available at http://www.giiconference.com/ima236697-2012/

Biologic Manufacturing China 2012

October 17 – 18, 2012 – Shanghai, China

The face of the biopharmaceutical sector is changing substantially, with rapid developments in both developed countries and emerging markets. By 2016, biologic therapeutics are forecast to account for 23% of the global medicine market creating a market of USD 158 billion.

Compared to chemical drug manufacturing, biologic manufacturers are challenged with more complex processes and stringent regulatory requirements. Better planning, more investment and more sophisticated knowledge of the technologies are required in both early development and scale up projects to achieve desired results. Biologic Manufacturing China 2012 has all the answers companies are looking for whether in early stage development, maturing into scale up manufacturing, or a mature international organization.

Register before August 10 and save $400! More information is available at http://www.giiconference.com/iqpc243588-2012/

2nd Annual Clinical Trial Supply Asia

October 15 – 16, 2012 – Singapore

With the surge in the clinical services market and an increase in demand for clinical logistics in Asia, three major challenges confront the clinical trial supply in Asia this year: 1) Regulatory affairs; 2) Cost and quality; and 3) Temperature controlled distribution. The 2nd Annual Clinical Trial Supply Asia 2012 summit will cover these three topics and more. This event is Asia's leading high-level platform for clinical trial supply directors and clinical trial project managers from leading pharmaceutical companies, biopharmaceutical companies and CROs. Attendees will hear what industry leaders have to say about implementing effective clinical trial supply strategies in Asia to achieve successful on-time delivery and minimize costs and risks.

Save up to $640 by registering before August 10!  More information is available at http://www.giiconference.com/iqpc246344-2012/

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, [email protected]

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

SOURCE Global Information, Inc.

Suggested Articles

Out of options, Tocagen will become Forte Biosciences’ route to the public markets through an all-stock reverse merger.

Reich co-founded Effector and served as its SVP of research but has moved on to take up the CSO position at Turning Point Therapeutics.

BioMarin’s hemophilia A drug has been set an Aug. 21 PDUFA date as the California biotech looks to gain a speedy approval.